WARBERG ASSET MANAGEMENT LLC Protagenic Therapeutics, Inc. Transaction History

WARBERG ASSET MANAGEMENT LLC portfolio value:

$12,000
portfolio value

WARBERG ASSET MANAGEMENT LLC quarter portfolio value change:

-79.60%
quarter

Protagenic Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -13.02% -42.72K shares -37K $0.03 285.49K
Q2 2022 share Decrease -9.35% -33.84K shares -29K $0.15 328.22K
Q1 2022 share Increase +99.45% 180.53K shares 9K $0.25 362.06K
Q4 2021 share Decrease -50.24% -183.25K shares -74K $0.33 181.53K